Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biologic and clinical importance of proinsulin.

× No keyword cloud information.

15 in total

1. Proinsulin: much more than a hormone precursor in development.

Authors: Catalina Hernández-Sánchez; Oscar Bártulos; Flora de Pablo
Journal: Rev Endocr Metab Disord Date: 2005-08 Impact factor: 6.514

Review 2. Adult nesidioblastosis: a case report and review of the literature.

Authors: R D Rinker; K Friday; F Aydin; B M Jaffe; L Lambiase
Journal: Dig Dis Sci Date: 1998-08 Impact factor: 3.199

3. Introduction of Arthur H. Rubenstein.

Authors: Kenneth S Polonsky
Journal: J Clin Invest Date: 2012-11-01 Impact factor: 14.808

4. Insulinoma with hyperproinsulinemia during hypoglycemia and loss of expression of vacuolar-type H(+)-ATPase (V-ATPase) in the tumor tissue.

Authors: A Hiura; E C Kim; T Ikahara; K Mishima; K Shindo; T Ohta; K Satake
Journal: Int J Pancreatol Date: 1999-02

Review 5. Kinetic aspects of compartmental storage and secretion of insulin and zinc.

Authors: G Gold; G M Grodsky
Journal: Experientia Date: 1984-10-15

Review 6. Proinsulin in development: New roles for an ancient prohormone.

Authors: C Hernández-Sánchez; A Mansilla; E J de la Rosa; F de Pablo
Journal: Diabetologia Date: 2006-04-05 Impact factor: 10.122

7. Insulin Wakayama: familial mutant insulin syndrome in Japan.

Authors: K Nanjo; M Miyano; M Kondo; T Sanke; S Nishimura; K Miyamura; K Inouye; B D Given; S J Chan; K S Polonsky
Journal: Diabetologia Date: 1987-02 Impact factor: 10.122

8. Biochemical and clinical implications of proinsulin conversion intermediates.

Authors: B D Given; R M Cohen; S E Shoelson; B H Frank; A H Rubenstein; H S Tager
Journal: J Clin Invest Date: 1985-10 Impact factor: 14.808

9. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.

Authors: K Nanjo; T Sanke; M Miyano; K Okai; R Sowa; M Kondo; S Nishimura; K Iwo; K Miyamura; B D Given
Journal: J Clin Invest Date: 1986-02 Impact factor: 14.808

10. Upstream AUGs in embryonic proinsulin mRNA control its low translation level.

Authors: Catalina Hernández-Sánchez; Alicia Mansilla; Enrique J de la Rosa; G Elisabeth Pollerberg; Encarna Martínez-Salas; Flora de Pablo
Journal: EMBO J Date: 2003-10-15 Impact factor: 11.598